BML Inc Relative Valuation - BML Inc

Watchlist Manager

Watchlist

Price: 4 015 JPY -1.23% Market Closed

Market Cap: ¥163.6B

	BML Inc TSE:4694	JP

Multiples-Based Value

The Multiples-Based Value of one BML Inc stock under the Base Case scenario is 2 525.49 JPY. Compared to the current market price of 4 015 JPY, BML Inc is Overvalued by 37%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

Multiples-Based Value

Base Case

Overvaluation 37%

Multiples-Based Value

Price ¥4 015

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
JP		BML Inc TSE:4694	150.5B JPY	1	19.9	4.5	8.3
US		CVS Health Corp NYSE:CVS	100.2B USD	0.2	56.7	14.3	14.3
US	C	Cigna Group XMUN:CGN	69.6B EUR	0.3	13.4	7.8	10
US		Cigna Corp NYSE:CI	73.4B USD	0.3	12.3	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.1B EUR	1.1	19.8	9.9	14.7
DE		Fresenius Medical Care AG XMUN:FME	23.8B EUR	1.2	24.3	9.3	17.2
US		Laboratory Corporation of America Holdings NYSE:LH	22.5B USD	1.6	25.6	12.3	17.8
US		Quest Diagnostics Inc NYSE:DGX	21.8B USD	2	22	11.9	16.1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.2B EUR	0.6	11.4	5.4	10.1
US		Guardant Health Inc NASDAQ:GH	11.4B USD	11.6	-27.4	-29.9	-27.2
US		DaVita Inc NYSE:DVA	10.3B USD	0.8	13.8	7.2	9.7

				Revenue Growth	P/S to Growth
JP		BML Inc TSE:4694	Average P/S: 1.9 1	5%	0.2
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	2%	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	2%	0.3
US		Guardant Health Inc NASDAQ:GH	11.6	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
JP		BML Inc TSE:4694	Average P/E: 21.9 19.9	13%	1.5
US		CVS Health Corp NYSE:CVS	56.7	90%	0.6
US	C	Cigna Group XMUN:CGN	13.4	19%	0.7
US		Cigna Corp NYSE:CI	12.3	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.8	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	24.3	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	25.6	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.4	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.4	N/A	N/A
US		DaVita Inc NYSE:DVA	13.8	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
JP		BML Inc TSE:4694	Average EV/EBITDA: 9.2 4.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	14.3	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.9	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.3	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.3	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.4	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.9	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
JP		BML Inc TSE:4694	Average EV/EBIT: 13.1 8.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	14.3	22%	0.7
US	C	Cigna Group XMUN:CGN	10	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.7	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	17.2	11%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	17.8	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16.1	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.1	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.2	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9

BML Inc
TSE:4694

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
BML Inc Competitors

See Also

Company

Help

Tools

Stocks

BML Inc TSE:4694

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples BML Inc Competitors

See Also

Company

Help

Tools

Stocks

BML Inc
TSE:4694

Competitors Multiples
BML Inc Competitors